Notice Number: NOT-NS-19-040
Key Dates
Release Date: March 7, 2019
NOT-NS-20-106.
RFA-NS-19-010
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
Purpose
The purpose of this notice is to inform interested applicants that the expiration Date for RFA-NS-19-010 "Optimization of Non-addictive Therapies (Small Molecules and Biologics) to Treat Pain (UG3/UH3 Clinical Trial Not Allowed)" will be extended by one council round (changes shown in bold italics below). An additional due date has been added to this FOA, June 4, 2019..
Currently Reads:
Part 1. Overview Information
Key Dates
| Application Due Date(s) | January 9, 2019 and March 6, 2019, by 5:00PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
AIDS Application Due Date(s) |
January 9, 2019 and March 6, 2019, by 5:00PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | March 2019 and June 2019 |
| Advisory Council Review | May 2019 and August 2019 |
| Earliest Start Date | June 2019 and September 2019 |
| Expiration Date | March 7, 2019 |
Modified to Read:
Part 1. Overview Information
Key Dates
| Application Due Date(s) | January 9, 2019, March 6, 2019, and June 4, 2019 by 5:00PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) | January 9, 2019, March 6, 2019, and June 4, 2019 by 5:00PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | March 2019, June 2019, October 2019 |
| Advisory Council Review | May 2010, August 2019, August 2019 |
| Earliest Start Date | June 2019, September 2019, February 2020 |
| Expiration Date | June 5, 2019 |
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Charles Cywin, Ph.D.
National Institute of Neurological Disorders and Stroke
Telephone: 301-496-1779
Email: [email protected]
and Human Services (HHS)
